Telemedicine & Digital Health UCITS ETF (EDOC)

Fund Summary

The Global X Telemedicine & Digital Health UCITS ETF (EDOC) seeks to invest in companies positioned to benefit from further advances in the field of telemedicine and digital health. This includes companies involved in Telemedicine, Health Care Analytics, Connected Health Care Devices, and Administrative Digitization.

Fund Objective

The Global X Telemedicine & Digital Health UCITS ETF (EDOC) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Telemedicine & Digital Health Index.

Why EDOC?

High Growth Potential

The global telemedicine market increased 35% from 2019 to 2020, exceeding $55bn. Forecasts suggest the market could reach nearly $300bn by 2028. (Source: "Telemedicine Market Size, Share & Trends Analysis Report By Component" Grand View Research, Feb 2021)

Structural Tailwinds

In 2019, an estimated half of the global population lacked essential health care services. As more underserved markets gain broadband access, telemedicine offers vast opportunity to bridge the divide. (Source: World Economic Forum)

New Consumer Preferences

The pandemic increased adoption of digital health services, with many turning to telemedicine for the first time, accelerating the theme’s reach.

How To Invest

Presently, Global X UCITS ETFs are best accessed either in consultation with a financial advisor or a broker qualified to purchase stocks, ETFs and other securities on behalf of clients. Brokerage and other fees may apply. Global X does not make any recommendations or endorsements.

Fund Details As of 17 Sep 2021

Key Facts

Primary Ticker EDOC
Primary ISIN IE00BLR6QB00
Inception Date 17 Dec 2020
Bloomberg Index Ticker SOLEDOC
Index Provider Solactive AG
Management Style Physical - Full Replication
Management Company Global X Management Company
Custodian BBH
Domicile Ireland

Stats & Fees

Fund AUM $11,984,427.47
Number of Holdings 40
Total Expense Ratio 0.68%
Ongoing Charges 0.68%
Distribution Frequency Semi-Annually

Regulatory

UCITS Compliant Yes
ISA Eligibility Yes
SIPP Available Yes
UK Reporting Status Yes

Further Details

Authorised Participants & Market Makers

Citigroup Global Markets, DRW Europe BV, Flow Traders BV, GHCO LLP, HSBC Bank PLC, Jane Street Financial Ltd, Mirae Asset Securities UK Ltd, Societe Generale SA, Susquehanna Intl Ltd

Registered Countries

Denmark, Finland, Germany, Ireland, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, UK

Fund Documents

Trading Information As of 17 Sep 2021

USD Accumulating (ISIN: IE00BLR6QB00)

Exchange Trading
Currency
Ticker Listing
Date
SEDOL Net Asset
Value (NAV)
Shares
Outstanding
Net
Assets
London Stock Exchange USD EDOC LN 18 Dec 2020 BLR6Q54 $15.17 (2.14%) 740,000 $11,225,993.90
Deutsche Börse Xetra EUR DDOC GY 04 Feb 2021 BLR6Q76
Bolsa Mexicana De Valores MXN EDOCU MX 25 Mar 2021
SIX Swiss Exchange CHF EDOC SW 16 Jul 2021 BNT8T75
Borsa Italiana EUR EDOC IM 09 Aug 2021 BMCHV21

USD Distributing (ISIN: IE00BLR6QC17)

Exchange Trading
Currency
Ticker Listing
Date
SEDOL Net Asset
Value (NAV)
Shares
Outstanding
Net
Assets
London Stock Exchange GBP EDOG LN 18 Dec 2020 BLR6Q98 $15.17 (2.15%) 50,000 $758,433.57

Performance History

As of 31 Aug 2021

Fund Index Relative
Last 12 Months -- -- --

Returns not available as there is less than 12 months of performance history.

Sector Breakdown As of 31 Aug 2021

% of Net Assets
Health Care 63.2
Information Technology 25.1
Communication Services 8.9
Industrials 1.9
Financials 0.7
Materials 0.3

Source: AltaVista Research, LLC

Country Breakdown As of 31 Aug 2021

% of Net Assets
United States 86.6
China 5.0
Japan 4.1
Germany 2.3
Hong Kong 2.1

Source: AltaVista Research, LLC

Top 10 Holdings As of 17 Sep 2021

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
5.58 DXCM DEXCOM INC B0796X4 563.14 1,188 669,010.32
5.47 A AGILENT TECHNOLOGIES INC 2520153 173.94 3,769 655,579.86
5.38 TNDM TANDEM DIABETES CARE INC BF3W461 122.43 5,268 644,961.24
4.82 2413 JP M3 INC B02K2M3 80.90 7,133 577,087.40
4.76 LH LABORATORY CP 2586122 295.93 1,929 570,848.97
4.76 OMCL OMNICELL INC 2789523 160.58 3,549 569,898.42
4.65 ILMN ILLUMINA INC 2613990 447.01 1,246 556,974.46
4.50 UNH UNITEDHEALTH GROUP INC 2917766 420.16 1,284 539,485.44
4.38 NUAN NUANCE COMMUNICATIONS INC 2402121 55.10 9,521 524,607.10
4.22 CERN CERNER CORP 2185284 75.04 6,741 505,844.64
Holdings are subject to change.

The value of an investment in ETFs may go down as well as up and past performance is not a reliable indicator of future performance.

Trading in ETFs may not be suitable for all types of investors as they carry a high degree of risk. You may lose all of your initial investment. Only speculate with money you can afford to lose. Changes in exchange rates may also cause your investment to go up or down in value. Tax treatment depends on the individual circumstances of each client and may be subject to change in the future. Please ensure that you fully understand the risks involved. If in any doubt, please seek independent financial advice. Investors should refer to the section entitled “Risk Factors” in the relevant prospectus for further details of these and other risks associated with an investment in the securities offered by the Issuer.